8IJC
NMR solution structure of the 1:1 complex of a platinum(II) ligand L1-transpt covalently bound to a G-quadruplex MYT1L
8IJC の概要
エントリーDOI | 10.2210/pdb8ijc/pdb |
分子名称 | G-quadruplex DNA MYT1L, Pt(NH3)2(2-(pyridin-4-ylmethyl)benzo-[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone) (2 entities in total) |
機能のキーワード | g-quadruplex dna, quadruplex-duplex hybrid, platinum complex, dna |
由来する生物種 | Homo sapiens |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 9803.36 |
構造登録者 | |
主引用文献 | Liu, L.Y.,Ma, T.Z.,Zeng, Y.L.,Liu, W.,Zhang, H.,Mao, Z.W. Organic-Platinum Hybrids for Covalent Binding of G-Quadruplexes: Structural Basis and Application to Cancer Immunotherapy. Angew.Chem.Int.Ed.Engl., 62:e202305645-e202305645, 2023 Cited by PubMed Abstract: G-quadruplexes (G4s) have been revived as promising therapeutic targets with the development of immunotherapy, but the G4-mediated immune response remains unclear. We designed a novel class of G4-binding organic-platinum hybrids, L -cispt and L -transpt, with spatial matching for G4 binding and G4 DNA reactivity for binding site locking. The solution structure of L -transpt-MYT1L G4 demonstrated the effectiveness of the covalent binding and revealed the covalent binding-guided dynamic balance, accompanied by the destruction of the A5-T17 base pairs to achieve the covalent binding of the platinum unit to N7 of the G6 residue. Furthermore, L -cispt- and L -transpt-mediated genomic dysfunction could activate the retinoic acid-induced gene I (RIG-I) pathway and induce immunogenic cell death (ICD). The use of L -cispt/L -transpt-treated dying cells as therapeutic vaccines stimulated a robust immune response and effectively inhibited tumor growth in vivo. Our findings highlight the importance of the rational combination of specific spatial recognition and covalent locking in G4-trageting drug design and their potential in immunotherapy. PubMed: 37464955DOI: 10.1002/anie.202305645 主引用文献が同じPDBエントリー |
実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)をダウンロード